Abraxane (albumin-bound paclitaxel) 100 mg, India, generic Abraxane contains albumin-bound paclitaxel and is used for approved cancer indications. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Payment on delivery. Contact +380996042415.
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Interchangeable drugs with the same active ingredient:
Abitaxel
Viztaxel
Intaxel
Canataxen
Mitotax
Mitotax-M
Neotaxel
Neotaxel-Zdorovye
Paclimedac
Paclinor 100
Paclinor 260
Paclitax
Paclitaxel "Ebeve"
Paclitaxel Actavis
Paclitaxel Amaxa
Paclitaxel Main
Paclitaxel-Vista
Paclitaxel-Lance
Paclitaxel-MB
Paclitaxel-Teva
Paclitaxel-Pharmex
Paklitero
Paklihop
Paktalik
Pantium
Praxel
Stritoxol
Taxaval
Taxol
Taxomeda
Tapaklet
Egilitax
Sindaxel
Intaxel
Indications:
Ovarian cancer. First-line chemotherapy for advanced disease or residual tumors (more than 1 cm in size) after laparotomy in combination with cisplatin.
Breast cancer. Adjuvant chemotherapy for patients with breast cancer with lymph node involvement, after treatment with anthracyclines and cyclophosphamide; primary chemotherapy for locally advanced or metastatic breast cancer in combination with anthracyclines or in combination with trastuzumab in the case of immunohistochemical overexpression of HER-2 (3+) oncoproteins or in the presence of contraindications to anthracycline therapy; monotherapy for metastatic breast cancer in patients who are not candidates for standard anthracycline therapy, or in case of ineffectiveness of previous anthracycline therapy.
Extensive non-small cell lung cancer (NSCLC). Combination chemotherapy with cisplatin in case of impossibility of surgical treatment and/or radiation therapy.
Kaposi's sarcoma in patients with AIDS. Second-line therapy for advanced Kaposi's sarcoma in patients with AIDS.
